Catalyst Alert: Amgen/Regeneron Patent Case Appeal Could Be Decided By April
January 10, 2017 at 09:06 AM EST
After the close on Monday, Amgen, Inc. (NASDAQ: AMGN) announced that the U.S. District Court of Delaware had denied the motion by Sanofi ...